ClinicalTrialsFinder

Depressive Disorder, Treatment-Resistant Clinical Trials in Bethesda, Maryland

1 recruitingBethesda, Maryland

Showing 1–1 of 1 trials

Recruiting
Phase 2

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

DepressionDepressive DisorderMolecular Mechanisms of Pharmacological Action+10 more
National Institute of Mental Health (NIMH)50 enrolled1 locationNCT06511908